Kangmei Pharma | 600518 - Marktkapitalisierung

Aktienkurs
1.71
Täglich Wechseln
-0.01 -0.58%
Monatlich
-2.84%
Jährlich
-11.86%
Q2 Prognose
1.69




Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Avita Medical AUD 105.47M 35.32M 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Dianthus Therapeutics USD 1.78B 215M 2025-12
Genomma Lab Internacional MXN 18.84B 719.4M 2026-04
Hypermarcas BRL 14.92B 706.02M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 29.18B 9.2B 2026-04
Jiangsu Hengrui CNY 360.41B 6.49B 2026-04
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Organon & Co USD 1.86B 916.43M 2025-12
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 14.34B 2.8B 2025-12
Wuxi Apptec CNY 269.45B 61.09B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12
Zz Pientze Pharmaceu CNY 86.94B 31.78B 2026-04